Improving cervical cancer screening thanks to the combined action of an HPV test and Artificial Intelligence. Cervical cancer is a humanitarian emergency, with over 90% of deaths related to this disease occurring in LMIC (low- and middle-income countries). Early detection makes it easy to eradicate pre-cancerous lesions. The MSF Foundation, in collaboration with MSF and Epicentre, has joined an international consortium dedicated to improving cervical cancer screening. Led by the NCI (National Cancer Institute) in the USA, this consortium is conducting a large-scale study on over 100,000 women to evaluate a new approach to cervical cancer screening: the PAVE (Human Papillomavirus and Automated Visual Evaluation) study. This new screening protocol holds real promise for change, and will drastically improve the situation for women and reduce mortality from this cancer in LMICs.
